Andrea S. Foulkes, ScD

Andrea S. Foulkes is Director of Biostatistics at Massachusetts General Hospital, Professor of Medicine, Harvard Medical School and Professor, Department of Biostatistics, Harvard T.H. Chan School of Public Health. Under her leadership, MGH Biostatistics faculty and staff serve as lead statisticians on over 170 NIH sponsored research projects across 28 MGH divisions and departments and contribute to $489 million in research funding.  

Dr. Foulkes has a 20-year active research program in statistical methods for precision medicine using high-dimensional molecular and cellular level data to inform clinical risk factors for complex disease phenotypes at the intersection of infectious disease and cardiovascular disease. Her statistical methods research is motivated and grounded in HIV/AIDS, cardiometabolic disease, inflammation and SARS-CoV-2/COVID-19 research. As PI on multiple NIH-funded awards, she is leading efforts to develop and evaluate principled statistical methods for interrogating the mechanistic underpinnings of complex diseases. 

Dr. Foulkes earned a ScD in Biostatistics from Harvard University and a BA in Mathematics from Brown University. 

Musie Ghebremicheal, PhD

Musie Ghebremichael is an Associate Professor at Harvard Medical School, an Associate Investigator at MGH Biostatistics and Director of Biostatistics and Database Cores at the Ragon Institute of MGH, MIT and Harvard. His primary research interest focuses on the application and development of statistical methods for HIV/AIDS, TB, and immunologic research.   

Dr. Ghebremichael earned his Ph.D. in Statistics from Rice University and did a post-doctoral fellowship at Yale University.   

David Cheng headshot

David Cheng, PhD

David Cheng is an Instructor of Investigation at MGH and an Instructor in Medicine at HMS. He collaborates with multiple groups at MGH, including the Division of General Internal Medicine and the Mongan Institute. His collaborative research includes work in cancer, autoimmune diseases, cardiovascular diseases, and health policy. His methodological research is in causal inference and data integration. He is particularly interested in developing methods and applications to facilitate comparative effectiveness research and precision medicine using electronic health records data. 

Dr. Cheng received a PhD in Biostatistics from Harvard University and a BA in Economics and Statistics from the University of Chicago. 

Placeholder graphic for headshots

Lori Chibnik, PhD

Lori Chibnik is a biostatistician and Assistant Professor with an appointment in the Department of Neurology at Massachusetts General Hospital and the Department of Epidemiology at the Harvard T.H. Chan School of Public Health. She received her MPH in International Health and her PhD in biostatistics from the Boston University where she worked on predictive modeling methods for disease risk.

Over her career, she has developed and assessed predictive models for diseases such as autoimmune diseases, HIV and pre-natal screening and continues to apply her methods to complex diseases. Her current research focuses primarily on genetics and genomics of Alzheimer’s Disease and dementia with an emphasis on longitudinal cohorts and cognition. She serves as the co-lead of the Data and Statistics Core of the Massachusetts Alzheimer’s Disease Research Center (MADRC) and Director of the Biostatistical Consulting Service in the Dept. of Neurology.

In addition to her research, she is internationally renowned for her training programs and innovative teaching techniques, having developed multiple courses in biostatistics for varied audiences, most recently a series specific to the needs of scientists in sub-Saharan Africa. Currently she directs the Global Initiative for Neuropsychiatric Genetics Education and Research (GINGER) program at the Harvard-Chan School and the Broad Institute of MIT and Harvard.